FDA Adverse Event Injury Summary report: N

ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2

MDR report key: 1021231 · Received March 28, 2008

Report

Report Number
2953200-2008-00170
Event Type
Injury
Date Received
March 28, 2008
Date of Event
February 29, 2008
Report Date
February 29, 2008
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS - INHERENT RISK OF PROCEDURE (CORONARY ARTERY DISSECTION). INCORRECT TECHNIQUE/PROCEDURE (INADVERTENT AIR INJECTION). CONCLUSIONS - DEVICE DISCARDED UNABLE TO FOLLOW UP (DELIVERY CATHETER). USER ERROR CONTRIBUTED TO EVENT (INADVERTENT AIR INJECTION).

Description of Event or Problem · 1

A 2.5MM DIAMETER X 14MM LENGTH. ENDEAVOR MX2 DRUG-ELUTING CORONARY STENT DELIVERY SYSTEM WAS SUCCESSFULLY IMPLANTED INTO A PT FOR THE TREATMENT OF A DIFFUSE MIDDLE TO PROXIMAL LAD LESION. THE LESION MORPHOLOGY WAS REPORTED TO BE MILD TORTUOSITY, MILD CALCIFICATION AND 85 PERCENT STENOSIS. THE LESION WAS PRE-DILATED. IT WAS REPORTED THAT THE PHYSICIAN WAS PREPARING FOR POST DEPLOYMENT ANGIOGRAM, WHEN THE INJECTION OF 10CC OF AIR WENT DOWN THE LAD CAUSING A SPIRAL DISSECTION. THE PHYSICIAN BELIEVES THAT THE DISSECTION WAS CAUSED BY AIR INJECTION IN WHICH OUR PRODUCTS WERE INVOLVED IN THE CASE, BUT THE PHYSICIAN DOES NOT BELIEVE THE SDS USED WAS THE CAUSE OF THE DISSECTED VESSEL. THE PT WAS SENT TO THE OR FOR CABG. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2 NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA UNK

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention